The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Open accessAbstract
Significant research and preclinical investment in cancer nanomedicine has produced several products, which have improved cancer care. Nevertheless, there exists a perception that cancer nanomedicine 'has not lived up to its promise' because the number of approved products and their clinical performance are modest. Many of these analyses do not consider the long clinical history and many clinical products developed from iron oxide nanoparticles. Iron oxide nanoparticles have enjoyed clinical use for about nine decades demonstrating safety, and considerable clinical utility and versatility. FDA-approved applications of iron oxide nanoparticles include cancer diagnosis, cancer hyperthermia therapy, and iron deficiency anemia. For cancer nanomedicine, this wealth of clinical experience is invaluable to provide key lessons and highlight pitfalls in the pursuit of nanotechnology-based cancer therapeutics. We review the clinical experience with systemic liposomal drug delivery and parenteral therapy of iron deficiency anemia (IDA) with iron oxide nanoparticles. We note that the clinical success of injectable iron exploits the inherent interaction between nanoparticles and the (innate) immune system, which designers of liposomal drug delivery seek to avoid. Magnetic fluid hyperthermia, a cancer therapy that harnesses magnetic hysteresis heating is approved for treating humans only with iron oxide nanoparticles. Despite its successful demonstration to enhance overall survival in clinical trials, this nanotechnology-based thermal medicine struggles to establish a clinical presence. We review the physical and biological attributes of this approach, and suggest reasons for barriers to its acceptance. Finally, despite the extensive clinical experience with iron oxide nanoparticles new and exciting research points to surprising immune-modulating potential. Recent data demonstrate the interactions between immune cells and iron oxide nanoparticles can induce anti-tumor immune responses. These present new and exciting opportunities to explore additional applications with this venerable technology. Clinical applications of iron oxide nanoparticles present poignant case studies of the opportunities, complexities, and challenges in cancer nanomedicine. They also illustrate the need for revised paradigms and multidisciplinary approaches to develop and translate nanomedicines into clinical cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 7×
“Perhaps the early (preclinical) successes of cancer drug-delivery nanomedicines were oversold, with promises that exceeded the pace of the science, prompting a range of reactions [7,9,27-32,37,268-274].”
BackgroundInfluentialMatsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Magnetism and Magnetic Materials
Coey, J. M. D. (2001) · Cambridge University Press eBooks · doi:10.1017/9781108775052 · Cited by 3,178
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Heating magnetic fluid with alternating magnetic field
Rosensweig, R. E. (2002) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(02)00706-0 · Cited by 2,551
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732
Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Jordan, A., Scholz, R., Wust, P., Fähling, H., & Felix, R. (1999) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(99)00088-8 · Cited by 1,494
Magnetism and Magnetic Materials
Perov, N. S. (2009) · Solid State Phenomena · doi:10.4028/b-lzb8ey · Cited by 1,454
There's plenty of room at the bottom
Feynman, R. P. (1999) · California Institute of Technology eBooks · doi:10.1201/b10107-3 · Cited by 1,444
Maier-Hauff, K., Ulrich, F., Nestler, D., Niehoff, H., Wust, P., Thiesen, B., Orawa, H., Budach, V., & Jordan, A. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0389-0 · Cited by 1,429
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,358
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
Basu, S., Binder, R. J., Suto, R., Anderson, K. M., & Srivastava, P. K. (2000) · International Immunology · doi:10.1093/intimm/12.11.1539 · Cited by 1,305
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912273 · Cited by 1,147
Selective Inductive Heating of Lymph Nodes
GILCHRIST, R. K., MEDAL, R., SHOREY, W. D., HANSELMAN, R. C., PARROTT, J. C., & TAYLOR, C. B. (1957) · Annals of Surgery · doi:10.1097/00000658-195710000-00007 · Cited by 1,091
Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia
Dewhirst, M. W., Viglianti, B. L., Lora-Michiels, M., Hanson, M., & Hoopes, P. J. (2003) · International Journal of Hyperthermia · doi:10.1080/0265673031000119006 · Cited by 1,014
Carrey, J., Mehdaoui, B., & Respaud, M. (2011) · Journal of Applied Physics · doi:10.1063/1.3551582 · Cited by 994
Magnetic Relaxation in Fine‐Particle Systems
Dormann, J. L., Fiorani, D., & Tronc, E. (1997) · Advances in Chemical Physics · doi:10.1002/9780470141571.ch4 · Cited by 983
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Cancer nanomedicine: A review of recent success in drug delivery
Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879
Fundamentals and advances in magnetic hyperthermia
Périgo, E. A., Hemery, G., Sandre, O., Ortega, D., Garaio, E., Plazaola, F., & Teran, F. J. (2015) · Applied Physics Reviews · doi:10.1063/1.4935688 · Cited by 836
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
Ventola, C. L. (2017) · Europe PMC (PubMed Central) · Cited by 835
Johannsen, M., Gneveckow, U., Eckelt, L., Feussner, A., WaldÖFner, N., Scholz, R., Deger, S., Wust, P., Loening, S. A., & Jordan, A. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500158360 · Cited by 798
Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., Feussner, A., von Deimling, A., Waldoefner, N., Felix, R., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9195-0 · Cited by 775
There’s plenty of room at the bottom
Feynman, R. P. (2011) · Resonance · doi:10.1007/s12045-011-0109-x · Cited by 762
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
Bertrand, N., Grenier, P., Mahmoudi, M., Lima, E. M., Appel, E. A., Dormont, F., Lim, J.-M., Karnik, R., Langer, R., & Farokhzad, O. C. (2017) · Nature Communications · doi:10.1038/s41467-017-00600-w · Cited by 708
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Min, Y., Roche, K. C., Tian, S., Eblan, M. J., McKinnon, K. P., Caster, J. M., Chai, S., Herring, L. E., Zhang, L., Zhang, T., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.113 · Cited by 701
Falk, M. H., & Issels, R. D. (2001) · International Journal of Hyperthermia · doi:10.1080/02656730150201552 · Cited by 646
Datta, N. R., Ordóñez, S. G., Gaipl, U. S., Paulides, M. M., Crezee, H., Gellermann, J., Marder, D., Puric, E., & Bodis, S. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.009 · Cited by 588
The anticancer immune response: indispensable for therapeutic success?
Zitvogel, L., Apetoh, L., Ghiringhelli, F., André, F., Tesniere, A., & Kroemer, G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35180 · Cited by 573
Park, E.-J., Bae, E., Yi, J., Kim, Y., Choi, K., Lee, S. H., Yoon, J., Lee, B. C., & Park, K. (2010) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2010.05.004 · Cited by 570
Materials engineering for immunomodulation
Hubbell, J. A., Thomas, S. N., & Swartz, M. A. (2009) · Nature · doi:10.1038/nature08604 · Cited by 561
The anthracyclines: will we ever find a better doxorubicin?
Weiss, R. B. (1992) · PubMed · Cited by 558
Martinez-Boubeta, C., Simeonidis, K., Makridis, A., Angelakeris, M., Iglesias, O., Guardia, P., Cabot, A., Yedra, L., Estradé, S., Peiró, F., et al. (2013) · Scientific Reports · doi:10.1038/srep01652 · Cited by 539
Self-citationJohannsen, M., Gneveckow, U., Thiesen, B., Taymoorian, K., Cho, C. H., Waldöfner, N., Scholz, R., Jordan, A., Loening, S. A., & Wust, P. (2007) · European Urology · doi:10.1016/j.eururo.2006.11.023 · Cited by 532
Magnetic particle hyperthermia—a promising tumour therapy?
Dutz, S., & Hergt, R. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/45/452001 · Cited by 525
Dutz, S., & Hergt, R. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.822993 · Cited by 522
A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy
Cho, N.-H., Cheong, T.-C., Min, J. H., Wu, J. H., Lee, S. J., Kim, D., Yang, J.-S., Kim, S., Kim, Y. K., & Seong, S.-Y. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.149 · Cited by 514
Nanomedicine review: clinical developments in liposomal applications
Beltrán-Gracia, E., López-Camacho, A., Higuera-Ciapara, I., Velázquez-Fernández, J. B., & Vallejo-Cardona, A. A. (2019) · Cancer Nanotechnology · doi:10.1186/s12645-019-0055-y · Cited by 513
Magnetic nanoparticles in nanomedicine: a review of recent advances
Wu, K., Su, D., Liu, J., Saha, R., & Wang, J.-P. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab4241 · Cited by 509
Usable Frequencies in Hyperthermia with Thermal Seeds
Atkinson, W. J., Brezovich, I. A., & Chakraborty, D. P. (1984) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.1984.325372 · Cited by 496
Magnetic nanoparticle hyperthermia for prostate cancer
Johannsen, M., Thiesen, B., Wust, P., & Jordan, A. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003745740 · Cited by 469
Hyperthermia: a Potent Enhancer of Radiotherapy
Horsman, M. R., & Overgaard, J. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.03.015 · Cited by 463
Human Vaccines & Immunotherapeutics: News
Riedmann, E. M. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26189 · Cited by 462
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
Jordan, A., Scholz, R., Maier-Hauff, K., van Landeghem, F. K. H., Waldoefner, N., Teichgraeber, U., Pinkernelle, J., Bruhn, H., Neumann, F., Thiesen, B., et al. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9059-z · Cited by 459
Wolfram, J., & Ferrari, M. (2019) · Nano Today · doi:10.1016/j.nantod.2019.02.005 · Cited by 436
Cancer theranostics: the rise of targeted magnetic nanoparticles
Cole, A. J., Yang, V. C., & David, A. E. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.03.001 · Cited by 425
Auerbach, M., Ballard, H., Trout, J. R., McIlwain, M., Ackerman, A., Bahrain, H., Balan, S., Barker, L., & Rana, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.119 · Cited by 414
Mahmoudi, K., Bouras, A., Bozec, D., Ivkov, R., & Hadjipanayis, C. (2018) · International Journal of Hyperthermia · doi:10.1080/02656736.2018.1430867 · Cited by 414
Self-citationMagnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs
Di Corato, R., Espinosa, A., Lartigue, L., Tharaud, M., Chat, S., Pellegrino, T., Ménager, C., Gazeau, F., & Wilhelm, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.036 · Cited by 412
Choi, Y. H., & Han, H.-K. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0370-4 · Cited by 406
Size-Dependent Heating of Magnetic Iron Oxide Nanoparticles
Tong, S., Quinto, C. A., Zhang, L., Mohindra, P., & Bao, G. (2017) · ACS Nano · doi:10.1021/acsnano.7b01762 · Cited by 401
The struggle for iron - a metal at the host-pathogen interface: Iron at the host-pathogen interface
Nairz, M., Schroll, A., Sonnweber, T., & Weiss, G. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01529.x · Cited by 398
Branquinho, L. C., Carrião, M. S., Costa, A. S., Zufelato, N., Sousa, M. H., Miotto, R., Ivkov, R., & Bakuzis, A. F. (2013) · Scientific Reports · doi:10.1038/srep02887 · Cited by 395
Self-citationPhysics of heat generation using magnetic nanoparticles for hyperthermia
Dennis, C. L., & Ivkov, R. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.836758 · Cited by 391
Self-citationJohannsen, M., Gneveckow, U., Taymoorian, K., Thiesen, B., Waldöfner, N., Scholz, R., Jung, K., Jordan, A., Wust, P., & Loening, S. A. (2007) · International Journal of Hyperthermia · doi:10.1080/02656730601175479 · Cited by 382
Martinez-Boubeta, C., Simeonidis, K., Makridis, A., Angelakeris, M., Iglesias, Ò., Guardia, P., Cabot, A., Yedra, L., Estradé, S., Peiró, F., et al. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 381
Self-citationEvaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Verslype, C., Rosmorduc, O., & Rougier, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds225 · Cited by 365
Gut microbiome in HCC – Mechanisms, diagnosis and therapy
Schwabe, R. F., & Greten, T. F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.016 · Cited by 363
Cancer Management: A Multidisciplinary Approach
Pazdur, R., Coia, L. R., Hoskins, W. J., & Wagman, L. D. (2007) · Cited by 354
Iron at the interface of immunity and infection
Nairz, M., Haschka, D., Demetz, E., & Weiss, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00152 · Cited by 325 · cited 1×
“infection [85,86]; and, nanoparticle-immune interactions, including iron oxide nanoparticles, are being explored as immune therapies or vaccines for infectious diseases and cancer [87-93].”
BackgroundEGFR-Targeted Magnetic Nanoparticle Heaters Kill Cancer Cells without a Perceptible Temperature Rise
Creixell, M., Bohórquez, A. C., Torres-Lugo, M., & Rinaldi, C. (2011) · ACS Nano · doi:10.1021/nn201822b · Cited by 325
Gordon, R. T., Hines, J. R., & Gordon, D. (1979) · Medical Hypotheses · doi:10.1016/0306-9877(79)90063-x · Cited by 310
Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
Auerbach, M., & Ballard, H. (2010) · Hematology · doi:10.1182/asheducation-2010.1.338 · Cited by 310
Current understanding of interactions between nanoparticles and the immune system
Dobrovolskaia, M. A., Shurin, M., & Shvedova, A. A. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.022 · Cited by 309
Local tumour hyperthermia as immunotherapy for metastatic cancer
Toraya-Brown, S., & Fiering, S. (2014) · International Journal of Hyperthermia · doi:10.3109/02656736.2014.968640 · Cited by 302
Self-citationEffects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
Oei, A. L., Vriend, L. E. M., Crezee, J., Franken, N. A. P., & Krawczyk, P. M. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0462-0 · Cited by 294
Wust, >., Gneveckow, U., Wust, >., Gneveckow, U., Johannsen, M., Böhmer, D., Henkel, T., Kahmann, F., Sehouli, J., Felix, R., et al. (2006) · International Journal of Hyperthermia · doi:10.1080/02656730601106037 · Cited by 294
Petersen, G. H., Alzghari, S. K., Chee, W., Sankari, S. S., & La-Beck, N. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.028 · Cited by 290
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Aapro, M., Beguin, Y., Bokemeyer, C., Dicato, M., Gascón, P., Glaspy, J., Hofmann, A., Link, H., Littlewood, T., Ludwig, H., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx758 · Cited by 288
De Jong, W. H., Van Der Ven, L. T. M., Sleijffers, A., Park, M. V. D. Z., Jansen, E. H. J. M., Van Loveren, H., & Vandebriel, R. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.048 · Cited by 284
Thermal fluctuations of magnetic nanoparticles: Fifty years after Brown
Coffey, W. T., & Kalmykov, Y. P. (2012) · Journal of Applied Physics · doi:10.1063/1.4754272 · Cited by 282
Multiplying Magnetic Hyperthermia Response by Nanoparticle Assembling
Serantes, D., Simeonidis, K., Angelakeris, M., Chubykalo-Fesenko, O., Marciello, M., Morales, M. D. P., Baldomir, D., & Martinez-Boubeta, C. (2014) · The Journal of Physical Chemistry C · doi:10.1021/jp410717m · Cited by 281
Self-citationIntravenous Iron Dextran in Clinical Medicine
Hamstra, R. D. (1980) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1980.03300430028018 · Cited by 280
Verbrugge, I., Hagekyriakou, J., Sharp, L. L., Galli, M., West, A., McLaughlin, N. M., Duret, H., Yagita, H., Johnstone, R. W., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0210 · Cited by 275
Autio, K. A., Dreicer, R., Anderson, J., Garcia, J. A., Alva, A., Hart, L. L., Milowsky, M. I., Posadas, E. M., Ryan, C. J., Graf, R. P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2168 · Cited by 275
Combined Magnetic Hyperthermia and Immune Therapy for Primary and Metastatic Tumor Treatments
Pan, J., Hu, P., Guo, Y., Hao, J., Ni, D., Xu, Y., Bao, Q., Yao, H., Wei, C., Wu, Q., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b08550 · Cited by 270
Yang, Q., Jones, S. W., Parker, C. L., Zamboni, W. C., Bear, J. E., & Lai, S. K. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400703d · Cited by 269
Material properties in complement activation
Moghimi, S. M., Andersen, A. J., Ahmadvand, D., Wibroe, P. P., Andresen, T. L., & Hunter, A. C. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.002 · Cited by 268
Magnetic fluid hyperthermia: Advances, challenges, and opportunity
Kozissnik, B., Bohorquez, A. C., Dobson, J., & Rinaldi, C. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.837200 · Cited by 267
Cataldi, M., Vigliotti, C., Mosca, T., Cammarota, M., & Capone, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061249 · Cited by 267
Nanomedicine in cancer therapy: Innovative trends and prospects
Blanco, E., Hsiao, A., Mann, A. P., Landry, M. G., Meric‐Bernstam, F., & Ferrari, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01941.x · Cited by 265
Jordan, A., Wust, P., Scholz, R., Tesche, B., Fähling, H., Mitrovics, T., Vogl, T., Cervós-navarro, J., & Felix, R. (1996) · International Journal of Hyperthermia · doi:10.3109/02656739609027678 · Cited by 259
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
Hartshorn, C. M., Bradbury, M. S., Lanza, G. M., Nel, A. E., Rao, J., Wang, A. Z., Wiesner, U. B., Yang, L., & Grodzinski, P. (2018) · ACS Nano · doi:10.1021/acsnano.7b05108 · Cited by 258
Dennis, C. L., Jackson, A. J., Borchers, J. A., Hoopes, P. J., Strawbridge, R., Foreman, A. R., van Lierop, J., Grüttner, C., & Ivkov, R. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/39/395103 · Cited by 254
Self-citationOld and new facts about hyperthermia-induced modulations of the immune system
Frey, B., Weiss, E.-M., Rubner, Y., Wunderlich, R., Ott, O. J., Sauer, R., Fietkau, R., & Gaipl, U. S. (2012) · International Journal of Hyperthermia · doi:10.3109/02656736.2012.677933 · Cited by 252
Wang, Z., Zhang, F., Shao, D., Chang, Z., Wang, L., Hu, H., Zheng, X., Li, X., Chen, F., Tu, Z., et al. (2019) · Advanced Science · doi:10.1002/advs.201901690 · Cited by 248
Temperature Matters! And Why It Should Matter to Tumor Immunologists
Repasky, E. A., Evans, S. S., & Dewhirst, M. W. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0118 · Cited by 243
Vallhov, H., Qin, J., Johansson, S. M., Ahlborg, N., Muhammed, M. A., Scheynius, A., & Gabrielsson, S. (2006) · Nano Letters · doi:10.1021/nl060860z · Cited by 238
Fisher, D. T., Chen, Q., Skitzki, J. J., Muhitch, J. B., Zhou, L., Appenheimer, M. M., Vardam, T. D., Weis, E. L., Passanese, J., Wang, W.-C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44952 · Cited by 229
Hong, R. L., Huang, C. J., Tseng, Y., Pang, V. F., Chen, S.-T., Liu, J. J., & Chang, F. (1999) · PubMed · Cited by 227
Chao, Y., Chen, G., Liang, C., Xu, J., Dong, Z., Han, X., Wang, C., & Liu, Z. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00579 · Cited by 222
Ruta, S., Chantrell, R., & Hovorka, O. (2015) · Scientific Reports · doi:10.1038/srep09090 · Cited by 219
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes
Symon, Z., Peyser, A., Tzemach, D., Lyass, O., Sucher, E., Shezen, E., & Gabizon, A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990701)86:1<72::aid-cncr12>3.0.co;2-1 · Cited by 213
Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense?
Rabin, Y. (2002) · International Journal of Hyperthermia · doi:10.1080/02656730110116713 · Cited by 212
To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes
Dou, Y., Hynynen, K., & Allen, C. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.025 · Cited by 210
Structure, chemistry, and pharmacokinetics of intravenous iron agents.
Danielson, B. G. (2004) · PubMed · doi:10.1097/01.asn.0000143814.49713.c5 · Cited by 208
Suriyanto, Ng, E. Y. K., & Kumar, S. D. (2017) · BioMedical Engineering OnLine · doi:10.1186/s12938-017-0327-x · Cited by 205
Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
Elming, P., Sørensen, B., Oei, A., Franken, N., Crezee, J., Overgaard, J., & Horsman, M. (2019) · Cancers · doi:10.3390/cancers11010060 · Cited by 205
Wei, M., Chen, N., Li, J., Yin, M., Liang, L., He, Y., Song, H., Fan, C., & Huang, Q. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201105187 · Cited by 202
DeNardo, S. J., DeNardo, G. L., Miers, L. A., Natarajan, A., Foreman, A. R., Gruettner, C., Adamson, G. N., & Ivkov, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1004-0022 · Cited by 200
Self-citationNanoparticle clearance is governed by Th1/Th2 immunity and strain background
Jones, S. W., Roberts, R. A., Robbins, G. R., Perry, J. L., Kai, M. P., Chen, K., Bo, T., Napier, M. E., Ting, J. P. Y., DeSimone, J. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66895 · Cited by 197
A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy
Mi, Y., Smith, C. C., Yang, F., Qi, Y., Roche, K. C., Serody, J. S., Vincent, B. G., & Wang, A. Z. (2018) · Advanced Materials · doi:10.1002/adma.201706098 · Cited by 196
Toraya-Brown, S., Sheen, M. R., Zhang, P., Chen, L., Baird, J. R., Demidenko, E., Turk, M. J., Hoopes, P. J., Conejo-Garcia, J. R., & Fiering, S. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.01.011 · Cited by 193
Self-citationRole of dipole-dipole interactions for hyperthermia heating of magnetic nanoparticle ensembles
Haase, C., & Nowak, U. (2012) · Physical Review B · doi:10.1103/physrevb.85.045435 · Cited by 193
Influence of dipolar interactions on hyperthermia properties of ferromagnetic particles
Serantes, D., Baldomir, D., Martinez-Boubeta, C., Simeonidis, K., Angelakeris, M., Natividad, E., Castro, M., Mediano, A., Chen, D.-X., Sanchez, A., et al. (2010) · Journal of Applied Physics · doi:10.1063/1.3488881 · Cited by 193
Self-citationMagnetic iron oxide nanoparticles for disease detection and therapy
Tong, S., Zhu, H., & Bao, G. (2019) · Materials Today · doi:10.1016/j.mattod.2019.06.003 · Cited by 190
Grauer, O., Jaber, M., Hess, K., Weckesser, M., Schwindt, W., Maring, S., Wölfer, J., & Stummer, W. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03005-x · Cited by 181
Nanomaterial-induced ferroptosis for cancer specific therapy
Liu, M., Liu, B., Liu, Q., Du, K., Wang, Z., & He, N. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.12.015 · Cited by 181
In vivo applications of magnetic nanoparticle hyperthermia
Hilger, I. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.832815 · Cited by 172
Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth
Kosmides, A. K., Sidhom, J.-W., Fraser, A., Bessell, C. A., & Schneck, J. P. (2017) · ACS Nano · doi:10.1021/acsnano.6b08152 · Cited by 170
Combination immunotherapy approaches
Drake, C. G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds262 · Cited by 168
Miller, K., Cortes, J., Hurvitz, S. A., Krop, I. E., Tripathy, D., Verma, S., Riahi, K., Reynolds, J. G., Wickham, T. J., Molnar, I., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2385-z · Cited by 168
A Single Picture Explains Diversity of Hyperthermia Response of Magnetic Nanoparticles
Conde-Leboran, I., Baldomir, D., Martinez-Boubeta, C., Chubykalo-Fesenko, O., del Puerto Morales, M., Salas, G., Cabrera, D., Camarero, J., Teran, F. J., & Serantes, D. (2015) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b02555 · Cited by 167
Self-citationTak, W. Y., Lin, S.-M., Wang, Y., Zheng, J., Vecchione, A., Park, S. Y., Chen, M. H., Wong, S., Xu, R., Peng, C.-Y., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2433 · Cited by 167
Evaluation of magnetic nanoparticles for magnetic fluid hyperthermia
Lanier, O. L., Korotych, O. I., Monsalve, A. G., Wable, D., Savliwala, S., Grooms, N. W. F., Nacea, C., Tuitt, O. R., & Dobson, J. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1628313 · Cited by 167
Wood, L. M., & Paterson, Y. Y. W. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00051 · Cited by 164
Relevancy of Drug Loading to Liposomal Formulation Therapeutic Efficacy
Barenholz, Y. (2003) · Journal of Liposome Research · doi:10.1081/lpr-120017482 · Cited by 161
Lung exposure to nanoparticles modulates an asthmatic response in a mouse model
Hussain, S., Vanoirbeek, J. A. J., Luyts, K., De Vooght, V., Verbeken, E., Thomassen, L. C. J., Martens, J. A., Dinsdale, D., Boland, S., Marano, F., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00168509 · Cited by 160
Korangath, P. C., Barnett, J. D., Sharma, A., Henderson, E. T., Stewart, J., Yu, S.-H., Kandala, S. K., Yang, C.-T., Caserto, J. S., Hedayati, M. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay1601 · Cited by 160
Self-citationMoon, E. J., Sonveaux, P., Porporato, P. E., Danhier, P., Gallez, B., Batinic-Haberle, I., Nien, Y.-C., Schroeder, T., & Dewhirst, M. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006646107 · Cited by 159
In Situ Measurement of Magnetization Relaxation of Internalized Nanoparticles in Live Cells
Soukup, D., Moise, S., Céspedes, E., Dobson, J., & Telling, N. D. (2015) · ACS Nano · doi:10.1021/nn503888j · Cited by 158
Handbook of cancer chemotherapy
(1993) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(93)90321-b · Cited by 158
Martinez-Boubeta, C., Simeonidis, K., Serantes, D., Conde‐Leborán, I., Kazakis, I. G., Stefanou, G. D., Peña, L. F., Galceran, R., Balcells, L., Monty, C., et al. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201200307 · Cited by 156
Self-citationCancer nanomedicines: oversold or underappreciated?
van der Meel, R., Lammers, T., & Hennink, W. E. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1262346 · Cited by 156
Iron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
Single-dose intravenous iron for iron deficiency: a new paradigm
Auerbach, M., & Deloughery, T. (2016) · Hematology · doi:10.1182/asheducation-2016.1.57 · Cited by 148
Grüttner, C., Müller, K., Teller, J., et al. (2006) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2006.10.1151 · Cited by 146
Park, E., Kim, H., Kim, Y., Yi, J., Choi, K., & Park, K. (2010) · Toxicology · doi:10.1016/j.tox.2010.06.002 · Cited by 144
Attaluri, A., Kandala, S. K., Wabler, M., Zhou, H., Cornejo, C. M., Armour, M., Hedayati, M. A., Zhang, Y., DeWeese, T. L., Herman, Č., et al. (2015) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1005178 · Cited by 144
Self-citationDeNardo, S. J., DeNardo, G. L., Natarajan, A., Miers, L. A., Foreman, A. R., Gruettner, C., Adamson, G. N., & Ivkov, R. (2007) · PubMed · Cited by 143
Self-citationBordelon, D. E., Cornejo, C., Grüttner, C., Westphal, F., DeWeese, T. L., & Ivkov, R. (2011) · Journal of Applied Physics · doi:10.1063/1.3597820 · Cited by 142
Self-citationImproving efficacy of hyperthermia in oncology by exploiting biological mechanisms
van den Tempel, N., Horsman, M. R., & Kanaar, R. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2016.1157216 · Cited by 137
Integrating Nanotechnology into Cancer Care
Grodzinski, P. A., Kircher, M. F., Goldberg, M. S., & Gabizón, A. (2019) · ACS Nano · doi:10.1021/acsnano.9b04266 · Cited by 137
Sharma, A., Bode, B., Wenger, R. H., Lehmann, K., Sartori, A. A., Moch, H., Knuth, A. K., von Boehmer, L., & van den Broek, M. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028217 · Cited by 135
Itô, A., Tanaka, K., Honda, H., et al. (2003) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(03)90138-1 · Cited by 133
Low frequency hysteresis loops of superparamagnetic nanoparticles with uniaxial anisotropy
Usov, N. A. (2010) · Journal of Applied Physics · doi:10.1063/1.3445879 · Cited by 129
Dennis, C. L., Krycka, K. L., Borchers, J. A., Desautels, R. D., van Lierop, J., Huls, N. A. F., Jackson, A., Gruettner, C., & Ivkov, R. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201500405 · Cited by 125
Self-citationHandbook of cancer chemotherapy
Griffiths, M. (1996) · European Journal of Cancer Part B Oral Oncology · doi:10.1016/s0964-1955(96)90004-4 · Cited by 120
Immunosuppressive and anti‐inflammatory properties of engineered nanomaterials
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12722 · Cited by 118
Kaewamatawong, T., Shimada, A., Okajima, M., Inoue, H., MORITA, T., Inoue, K., & Takano, H. (2006) · Toxicologic Pathology · doi:10.1080/01926230601094552 · Cited by 118
Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics
Marchal, S., Hor, A. E., Millard, M., Gillon, V., & Bezdetnaya, L. (2015) · Drugs · doi:10.1007/s40265-015-0453-3 · Cited by 117
Salloum, M., Ma, R., & Zhu, L. K. (2008) · International Journal of Hyperthermia · doi:10.1080/02656730802203377 · Cited by 117
Selective Depletion of Nonspecific T Cells During the Early Stage of Immune Responses to Infection
Jiang, J. K., Lau, L. L., & Shen, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4352 · Cited by 116
In-situ particles reorientation during magnetic hyperthermia application: Shape matters twice
Simeonidis, K., Morales, M. P., Marciello, M., Angelakeris, M., de la Presa, P. M., Lázaro-Carrillo, A., Tabero, A., Villanueva, Á., Chubykalo‐Fesenko, O., & Serantes, D. (2016) · Scientific Reports · doi:10.1038/srep38382 · Cited by 113
Self-citationBakker, A., van der Zee, J., van Tienhoven, G., Kok, H. P., Rasch, C. R. N., & Crezee, J. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1665718 · Cited by 112
NanoFerrite Particle Based Radioimmunonanoparticles: Binding Affinity and In Vivo Pharmacokinetics
Natarajan, A., Gruettner, C., Ivkov, R., DeNardo, G. L., Mirick, G. R., Yuan, A., Foreman, A. R., & DeNardo, S. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800015n · Cited by 110
Self-citationIssels, R. D., Kampmann, E., Kanaar, R., & Lindner, L. H. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1119317 · Cited by 110
Principles of Oncologic Pharmacotherapy
Takimoto, C. H. M., & Calvo, E. (2005) · Cited by 110
Intravenous iron: From anathema to standard of care
Auerbach, M., Coyne, D., & Ballard, H. S. (2008) · American Journal of Hematology · doi:10.1002/ajh.21154 · Cited by 109
Pedersen, M. B., Zhou, X., Larsen, E., Sørensen, U. B. S., Kjems, J., Nygaard, J. V., Nyengaard, J. R., Meyer, R. L., Boesen, T. P., & Vorup‐Jensen, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902214 · Cited by 106
Commercialization of nanotechnology
Hobson, D. W. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.28 · Cited by 106
Kirschbaum, K., Sonner, J. K., Zeller, M. W. G., Deumelandt, K., Bode, J., Sharma, R. K., Krüwel, T., Fischer, M. D., Hoffmann, A., da Silva, M. C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609397113 · Cited by 106
Effector CD8 + T cell IFN- γ production and cytotoxicity are enhanced by mild hyperthermia
Mace, T. A., Zhong, L., Kokolus, K. M., & Repasky, E. A. (2012) · International Journal of Hyperthermia · doi:10.3109/02656736.2011.616182 · Cited by 105
Dennis, C. L., Jackson, A., Borchers, J. A., Ivkov, R., Foreman, A. R., Lau, J. W., Goernitz, E., & Gruettner, C. (2008) · Journal of Applied Physics · doi:10.1063/1.2837647 · Cited by 105
Self-citationSuzuki, M., Shinkai, M., Honda, H., & Kobayashi, T. (2003) · Melanoma Research · doi:10.1097/00008390-200304000-00004 · Cited by 103
Clinical Trials of Thermosensitive Nanomaterials: An Overview
Nardecchia, S., Sánchez‐Moreno, P., de Vicente, J., Marchal, J. A., & Boulaiz, H. (2019) · Nanomaterials · doi:10.3390/nano9020191 · Cited by 103
Colloidal Flower‐Shaped Iron Oxide Nanoparticles: Synthesis Strategies and Coatings
Gavilán, H., Kowalski, A., Heinke, D., Sugunan, A., Sommertune, J., Varón, M., Bogart, L. K., Posth, O., Zeng, L. J., González‐Alonso, D., et al. (2017) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201700094 · Cited by 96
Occupational handling of nickel nanoparticles: A case report
Journeay, W. S., & Goldman, R. H. (2014) · American Journal of Industrial Medicine · doi:10.1002/ajim.22344 · Cited by 95
Knippertz, I., Stein, M. F., Dörrie, J., Schaft, N., Müller, I., Deinzer, A., Steinkasserer, A., & Nettelbeck, D. M. (2011) · International Journal of Hyperthermia · doi:10.3109/02656736.2011.589234 · Cited by 94
Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications
Grüttner, C., Müller, K., Teller, J., & Westphal, F. (2013) · International Journal of Hyperthermia · doi:10.3109/02656736.2013.835876 · Cited by 94
Hyperthermia: Cancer Treatment and Beyond
Bettaieb, A., Paulina, K., & Diana, A. (2013) · InTech eBooks · doi:10.5772/55795 · Cited by 93
Cancer Treatment - Conventional and Innovative Approaches
Rangel, L. (2013) · InTech eBooks · doi:10.5772/45937 · Cited by 91
Radiotherapy augments the immune response to prostate cancer in a time‐dependent manner
Harris, T. J., Hipkiss, E. L., Borzillary, S., Wada, S., Grosso, J. F., Yen, H., Getnet, D., Bruno, T. C., Goldberg, M. V., Pardoll, D. M., et al. (2008) · The Prostate · doi:10.1002/pros.20794 · Cited by 89
Intravenous Irons: From Basic Science to Clinical Practice
Bhandari, S., Pereira, D. I. A., Chappell, H. F., & Drakesmith, H. (2018) · Pharmaceuticals · doi:10.3390/ph11030082 · Cited by 89
Biological and Medical Aspects of Electromagnetic Fields
Wood, A. W., & Loughran, S. P. (2018) · CRC Press eBooks · doi:10.1201/9781315186641 · Cited by 88
Soetaert, F., Kandala, S. K., Bakuzis, A. F., & Ivkov, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-07088-w · Cited by 84
Self-citationAccurate measurement of the specific absorption rate using a suitable adiabatic magnetothermal setup
Natividad, E., Castro, M., & Mediano, A. (2008) · Applied Physics Letters · doi:10.1063/1.2891084 · Cited by 82
Enhancing immune responses to tumor-associated antigens
Higgins, J. P., Bernstein, M. B., & Hodge, J. W. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.15.9133 · Cited by 80
Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge
An, S. S. A., Kim, C.-S., Nguyen, H.-D., Ignacio, R. M. C., Kim, J.-H., Cho, H.-C., Meang, E.-H., Kim, Y., Kim, M.-K., Park, B.-K., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s57935 · Cited by 80
Jan, T., Shen, Wang, C., & Liao (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s21019 · Cited by 79
Druckmann, S., Gabizón, A., & Barenholz, Y. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90329-5 · Cited by 77
Nanoparticles and direct immunosuppression
Ngobili, T. A., & Daniele, M. A.-A. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216650053 · Cited by 76
Current Cancer Treatment - Novel Beyond Conventional Approaches
(2011) · InTech eBooks · doi:10.5772/897 · Cited by 75
Sav, T., Tokgöz, B., Sipahioğlu, M. H., Deveci, M., Sarı, İ., Oymak, O., & Utaş, C. (2007) · Renal Failure · doi:10.1080/08860220701278208 · Cited by 71
Thermoradiotherapy planning: Integration in routine clinical practice
Crezee, J., van Leeuwen, C. M., Oei, A. L., Stalpers, L. J. A., Bel, A., Franken, N. A. P., & Kok, H. P. (2015) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1110757 · Cited by 70
A standardisation protocol for accurate evaluation of specific loss power in magnetic hyperthermia
Makridis, A., Curto, S., van Rhoon, G. C., Samaras, T., & Angelakeris, M. (2019) · Journal of Physics D Applied Physics · doi:10.1088/1361-6463/ab140c · Cited by 68
Optimizing Magnetic Nanoparticle Based Thermal Therapies Within the Physical Limits of Heating
Etheridge, M. L., & Bischof, J. C. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0633-1 · Cited by 64
Cited by
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,062
Magnetic nanoparticles in biomedical applications: A review
Materón, E. M., Miyazaki, C. M., Carr, O., Joshi, N., Picciani, P. H. S., Dalmaschio, C. J., Davis, F., & Shimizu, F. M. (2021) · Applied Surface Science Advances · doi:10.1016/j.apsadv.2021.100163 · Cited by 456
Nanozyme for tumor therapy: Surface modification matters
Tang, G., He, J., Liu, J., Yan, X., & Fan, K. (2021) · Exploration · doi:10.1002/exp.20210005 · Cited by 441
Emerging Trends of Carbon‐Based Quantum Dots: Nanoarchitectonics and Applications
Guan, X., Li, Z., Geng, X., Lei, Z., Karakoti, A., Wu, T., Kumar, P., Yi, J., & Vinu, A. (2023) · Small · doi:10.1002/smll.202207181 · Cited by 305
Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives
Montiel Schneider, M. G., Martín, M. J., Otarola, J., Vakarelska, E., Simeonov, V., Lassalle, V., & Nedyalkova, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010204 · Cited by 302
Metadata
- Authors
- Soetaert, F., Korangath, P., Serantes, D., Fiering, S., & Ivkov, R.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 163-164
- Pages
- 65-83
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3037095003
- Cited by
- 406
- References
- 242
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.